A U.S. Food and Drug Administration (FDA) advisory committee recently determined that phenylephrine, an ingredient commonly used to treat sinus and nasal congestion, is ineffective in treating these symptoms. This was apparent from research for years, yet large...
News
Latest News
Rubio Habla en La Poderosa
El senador estadounidense Marco Rubio (R-FL) habló con César Grajales de La Poderosa 670 AM en El Panorama Político, sobre la crisis fronteriza, sobre cómo los hispanoamericanos se ven afectados con la realidad del país, sobre los cargos contra el senador Bob Menéndez...
Rubio, Colleagues Reintroduce Bill to Protect Rights of Pregnant Students
Pregnant students are sometimes discriminated against by their schools, either intentionally or unintentionally and there is a concerning lack of awareness about the resources and rights available to them. Due to a lack of services and discrimination, these women may...
Rubio, Colleagues Reintroduce Intelligence Community Workforce Agility Protection Act
Currently, intelligence community civilians are subject to certain tax penalties for job-related relocation requirements, but active-duty military servicemembers are not subjected to the same penalties. These tax benefits, including the ability to deduct moving...
Rubio Delivers Remarks at Senate Intelligence Hearing
Vice Chairman of the Senate Select Committee on Intelligence Marco Rubio (R-FL) delivered opening remarks and questioned witnesses at a hearing on countering China’s influence in the United States. Watch Rubio’s opening remarks here as well as Part I and Part II of...
Rubio-led Resolution to Raise Awareness for Spinal Cord Injuries Passes Senate
Approximately 302,000 Americans live with spinal cord injuries. To help these people achieve a better quality of life, there is a need to increase education and invest in research. U.S. Senators Marco Rubio (R-FL) and Tammy Baldwin (D-WI) successfully led a bipartisan...
National Ovarian Cancer Awareness Month
Senator Rubio marked National Ovarian Cancer Awareness Month submitting the following Statement for the Record:
Mr. President, I rise today to express support for women across America who are battling ovarian cancer and their families and friends who stand with them in their fight. It is estimated 22,280 women will be diagnosed with ovarian cancer this year. Of these women, 15,500 of them will lose the battle against this disease – 1,040 of the women who will lose the battle this year live in Florida. To put those numbers in perspective, this year, across America, three percent of new cancer diagnoses in women will be ovarian cancer, but ovarian cancer will account for six percent of female cancer deaths this year.
September marks National Ovarian Cancer Awareness Month, which is why I chose now to bring attention to this disease. Ovarian cancer is the ninth most common cancer in women and the fifth leading cause of cancer-related deaths because ovarian cancer is a unique cancer – there are no screening tests or early detection tests available. However, if ovarian cancer is treated before it has spread past the ovary, the five-year survival rate is 93 percent. Sadly, only 15 percent of ovarian cancer diagnoses happen in this early stage, making the overall five-year survival a mere 46 percent.
Until a screening test is developed, the best we can do to protect our wives, daughters, sisters, nieces, mothers, grandmothers, aunts, and friends is to bring awareness to the risk factors, signs, and symptoms of ovarian cancer. I urge my colleagues to help educate women about the potential warning signs to help with early diagnosis, which is the best method to save lives.